Vaccine Efficacy Estimands Implied by Common Estimators Used in Individual Randomized Field Trials
Michael P. Fay, Dean Follmann, Bruce J. Swihart, and Lauren E. Dang

TL;DR
This paper analyzes how common estimators in vaccine trials imply different vaccine efficacy estimands, discussing their interpretation, approximation quality, and potential biases over time.
Contribution
It provides a nonparametric formulation of VE estimands, compares their approximations, and discusses interpretational challenges and sensitivity analyses in vaccine efficacy studies.
Findings
Ratio effects are approximately equal at low event rates.
Full immunization estimands exclude early events before vaccine ramp-up.
Local VE estimands face interpretational difficulties like depletion of susceptibles bias.
Abstract
We review vaccine efficacy (VE) estimands for susceptibility in individual randomized trials with natural (unmeasured) exposure, where individual responses are measured as time from vaccination until an event (e.g., disease from the infectious agent). Common VE estimands are written as , where is some ratio effect measure (e.g., ratio of incidence rates, cumulative incidences, hazards, or odds) comparing outcomes under vaccination versus control. Although the ratio effects are approximately equal with low control event rates, we explore the quality of that approximation using a nonparametric formulation. Traditionally, the primary endpoint VE estimands are full immunization (or biological) estimands that represent a subset of the intent-to-treat population, excluding those that have the event before the vaccine has been able to ramp-up to its full effect, requiring…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Vaccine Coverage and Hesitancy · Statistical Methods in Clinical Trials
